Company: CGC
Filing Date: 2025-05-29
Form Type: POSASR
Source: 0001104659-25-054285
Chunk: 2

Company: Canopy Growth Corp
Filing Date: 2025-05-29
Form: POSASR
Chunk 2
---
, as amended) when it files its Annual Report on Form 10-K for the fiscal year ended March 31, 2025. Accordingly, the Company is filing this Post-Effective Amendment No. 1 for the purpose of including disclosure required for a registrant other than a well-known seasoned issuer, identifying the securities being registered, registering a specific amount of securities and paying the associated filing fee. This Post-Effective Amendment No. 1 contains:

•

a base prospectus which covers the offering, issuance and sale by the Company of up to $500,000,000 of the Company’s common shares, exchangeable shares, debt securities, subscription receipts, units and/or warrants, in each case from time to time in one or more offerings (the “Base Prospectus”);

•

an equity distribution agreement prospectus supplement (the “Equity Distribution Agreement Prospectus Supplement”) covering the offering, issuance and sale by the Company of up to a maximum aggregate offering price of $172,069,635 of the Company’s common shares that may be issued and sold from time to time under the Equity Distribution Agreement, dated February 28, 2025, entered into by the Company with BMO Capital Markets Corp. and BMO Nesbitt Burns Inc. (the “Equity Distribution Agreement”); and

•

a resale prospectus covering the offer and sale by the selling securityholders identified therein from time to time of up to 21,856,810 of the Company’s common shares (the “Resale Prospectus”).

The Base Prospectus immediately follows this explanatory note. The specific terms of any securities to be offered pursuant to the Base Prospectus will be specified in a prospectus supplement to the Base Prospectus.

The specific terms of the securities to be issued and sold under the Equity Distribution Agreement are specified in the Equity Distribution Agreement Prospectus Supplement, which immediately follows the Base Prospectus. The $172,069,635 of the Company’s common shares available for issuance as of May 29, 2025 that may be offered, issued, and sold under the Equity Distribution Agreement Prospectus Supplement is included in the $500,000,000 of securities that may be offered, issued, and sold by the Company under the Base Prospectus. Upon termination of the Equity Distribution Agreement, any portion of the $172,069,635 included in the Equity Distribution Agreement Prospectus Supplement that is not sold pursuant to the Equity Distribution Agreement will be available for sale in other offerings pursuant to the Base Prospectus and a corresponding prospect